Data mining of cancer vaccine trials

A bird's-eye view

Xiaohong Cao, Karen B. Maloney, Vladimir Brusic

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background. A wealth of information on clinical trials has been provided by publicly accessible online registries. Information technology and data exchange standards enable rapid extraction, summarization, and visualization of information and derived knowledge from these data sets. Clinical trials data was extracted in the XML format from the National Library of Medicine ClinicalTrials.gov site. This data includes categories such as 'Summary of Purpose', 'Trial Sponsor', 'Phase of the Trial', 'Recruiting Status', and 'Location'. We focused on 645 clinical trials related to cancer vaccines. Additional facts on cancer types, including incidence and survival rates, were retrieved from the National Cancer Institute Surveillance data. Results. This application enables rapid extraction of information about institutions, diseases, clinical approaches, clinical trials dates, predominant cancer types in the trials, clinical opportunities and pharmaceutical market coverage. Presentation of results is facilitated by visualization tools that summarize the landscape of ongoing and completed cancer vaccine trials. Our summaries show the number of clinical vaccine trials per cancer type, over time, by phase, by lead sponsors, as well as trial activity relative to cancer type and survival data. We also have identified cancers that are neglected in the cancer vaccine field: bladder, liver, pancreatic, stomach, esophageal, and all of the low-incidence cancers. Conclusion. We have developed a data mining approach that enables rapid extraction of complex data from the major clinical trial repository. Summarization and visualization of these data represents a cost-effective means of making informed decisions about future cancer vaccine clinical trials.

Original languageEnglish
Article number7
JournalImmunome Research
Volume4
Issue number1
DOIs
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Cancer Vaccines
Data Mining
Vaccines
Vaccine
Data mining
Cancer
Clinical Trials
Visualization
Neoplasms
Electronic data interchange
Summarization
XML
Liver
Drug products
Medicine
Information technology
National Library of Medicine (U.S.)
Incidence
Decision making
National Cancer Institute (U.S.)

ASJC Scopus subject areas

  • Immunology
  • Molecular Biology
  • Computational Theory and Mathematics
  • Applied Mathematics
  • Computer Science Applications

Cite this

Data mining of cancer vaccine trials : A bird's-eye view. / Cao, Xiaohong; Maloney, Karen B.; Brusic, Vladimir.

In: Immunome Research, Vol. 4, No. 1, 7, 2008.

Research output: Contribution to journalArticle

Cao, Xiaohong ; Maloney, Karen B. ; Brusic, Vladimir. / Data mining of cancer vaccine trials : A bird's-eye view. In: Immunome Research. 2008 ; Vol. 4, No. 1.
@article{02193e3281a843a9aae83403ae1ccabe,
title = "Data mining of cancer vaccine trials: A bird's-eye view",
abstract = "Background. A wealth of information on clinical trials has been provided by publicly accessible online registries. Information technology and data exchange standards enable rapid extraction, summarization, and visualization of information and derived knowledge from these data sets. Clinical trials data was extracted in the XML format from the National Library of Medicine ClinicalTrials.gov site. This data includes categories such as 'Summary of Purpose', 'Trial Sponsor', 'Phase of the Trial', 'Recruiting Status', and 'Location'. We focused on 645 clinical trials related to cancer vaccines. Additional facts on cancer types, including incidence and survival rates, were retrieved from the National Cancer Institute Surveillance data. Results. This application enables rapid extraction of information about institutions, diseases, clinical approaches, clinical trials dates, predominant cancer types in the trials, clinical opportunities and pharmaceutical market coverage. Presentation of results is facilitated by visualization tools that summarize the landscape of ongoing and completed cancer vaccine trials. Our summaries show the number of clinical vaccine trials per cancer type, over time, by phase, by lead sponsors, as well as trial activity relative to cancer type and survival data. We also have identified cancers that are neglected in the cancer vaccine field: bladder, liver, pancreatic, stomach, esophageal, and all of the low-incidence cancers. Conclusion. We have developed a data mining approach that enables rapid extraction of complex data from the major clinical trial repository. Summarization and visualization of these data represents a cost-effective means of making informed decisions about future cancer vaccine clinical trials.",
author = "Xiaohong Cao and Maloney, {Karen B.} and Vladimir Brusic",
year = "2008",
doi = "10.1186/1745-7580-4-7",
language = "English",
volume = "4",
journal = "Immunome Research",
issn = "1745-7580",
publisher = "OMICS Publishing Group",
number = "1",

}

TY - JOUR

T1 - Data mining of cancer vaccine trials

T2 - A bird's-eye view

AU - Cao, Xiaohong

AU - Maloney, Karen B.

AU - Brusic, Vladimir

PY - 2008

Y1 - 2008

N2 - Background. A wealth of information on clinical trials has been provided by publicly accessible online registries. Information technology and data exchange standards enable rapid extraction, summarization, and visualization of information and derived knowledge from these data sets. Clinical trials data was extracted in the XML format from the National Library of Medicine ClinicalTrials.gov site. This data includes categories such as 'Summary of Purpose', 'Trial Sponsor', 'Phase of the Trial', 'Recruiting Status', and 'Location'. We focused on 645 clinical trials related to cancer vaccines. Additional facts on cancer types, including incidence and survival rates, were retrieved from the National Cancer Institute Surveillance data. Results. This application enables rapid extraction of information about institutions, diseases, clinical approaches, clinical trials dates, predominant cancer types in the trials, clinical opportunities and pharmaceutical market coverage. Presentation of results is facilitated by visualization tools that summarize the landscape of ongoing and completed cancer vaccine trials. Our summaries show the number of clinical vaccine trials per cancer type, over time, by phase, by lead sponsors, as well as trial activity relative to cancer type and survival data. We also have identified cancers that are neglected in the cancer vaccine field: bladder, liver, pancreatic, stomach, esophageal, and all of the low-incidence cancers. Conclusion. We have developed a data mining approach that enables rapid extraction of complex data from the major clinical trial repository. Summarization and visualization of these data represents a cost-effective means of making informed decisions about future cancer vaccine clinical trials.

AB - Background. A wealth of information on clinical trials has been provided by publicly accessible online registries. Information technology and data exchange standards enable rapid extraction, summarization, and visualization of information and derived knowledge from these data sets. Clinical trials data was extracted in the XML format from the National Library of Medicine ClinicalTrials.gov site. This data includes categories such as 'Summary of Purpose', 'Trial Sponsor', 'Phase of the Trial', 'Recruiting Status', and 'Location'. We focused on 645 clinical trials related to cancer vaccines. Additional facts on cancer types, including incidence and survival rates, were retrieved from the National Cancer Institute Surveillance data. Results. This application enables rapid extraction of information about institutions, diseases, clinical approaches, clinical trials dates, predominant cancer types in the trials, clinical opportunities and pharmaceutical market coverage. Presentation of results is facilitated by visualization tools that summarize the landscape of ongoing and completed cancer vaccine trials. Our summaries show the number of clinical vaccine trials per cancer type, over time, by phase, by lead sponsors, as well as trial activity relative to cancer type and survival data. We also have identified cancers that are neglected in the cancer vaccine field: bladder, liver, pancreatic, stomach, esophageal, and all of the low-incidence cancers. Conclusion. We have developed a data mining approach that enables rapid extraction of complex data from the major clinical trial repository. Summarization and visualization of these data represents a cost-effective means of making informed decisions about future cancer vaccine clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=60349107677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60349107677&partnerID=8YFLogxK

U2 - 10.1186/1745-7580-4-7

DO - 10.1186/1745-7580-4-7

M3 - Article

VL - 4

JO - Immunome Research

JF - Immunome Research

SN - 1745-7580

IS - 1

M1 - 7

ER -